The men’s health technology startup RxMen, based in Delhi, has raised Rs 5 crore, or about $570K, in its seed round, which was led by Inflection Point Ventures (IPV). In addition, SPA Family Ventures, Ankit Goel, Seven Square Ventures, and a grant from Prosus Group participated in the round.
The money raised will be utilized to establish co-branded clinics, launch RxMen-branded goods, and develop the brand. By October 2025, the company hopes to have positive EBITDA.
RxMen is a full-stack, clinic-led men’s health platform that was founded in 2023 by Shailja Mittal. It emphasizes treating the underlying causes of issues with hormones, skin, stress, sleep, and sexual health.
According to RxMen, their revenue has increased 100 times in the last 20 months. They recently reported an MRR of $70,000 (as of August 2025), with an ARR projection of $1.7 million by FY26. More than 30,000 consultations have already been provided, and it currently handles 6,000 consultations per month through a network of 30 urology, psychiatry, sexology, and therapy specialists.
Additionally, RxMen created a Sexual Health Index (SHI) based on 25,000 anonymized consultations, which is currently being validated at IIT Jodhpur. According to SHI results, it claims a 95% success rate.
It will face competition from Traya, Bold Care, and Man Matters (Mosaic Wellness).
